15/11/2023

Lovexair highlights the future for lung health research: Digital health insights

Powered by EHTEL member, Lovexair Foundation

The Lovexair Foundation, new EHTEL member, is reaching out to launch the registrations for the 5th Ibero-American Summit for the Respiratory Community | The future for lung health research. This is Lovexair's 2023 online and free event due to take place on December 5th and 6th, 2023. It is aimed at respiratory patients, caregivers, healthcare professionals, and individuals interested in learning more about opportunities and trends in global lung health research.

Read more

14/11/2023

Artificial intelligence for rare diseases: the AI4NEF project

Powered by EHTEL member, Kelyon

Artificial intelligence (AI) is proving to be an increasingly valuable tool for medicine, also in the field of rare diseases.

AI4NEF is an example of an application of advanced technology to address a rare genetic disorder, neurofibromatosis type 1 (NF1) which can be inherited or develop spontaneously. The high variability and complex progression of NF1 symptoms require a multidisciplinary and holistic approach, making research on this disorder particularly challenging.

Read more

09/11/2023

The European Health Union: For your reading interest

On 29 November 2023, Mr Vytenis Andriukaitis will be the keynote speaker who closes EHTEL’s 2023 Symposium. His topic: The European Health Union. Ahead of attending the Symposium, take a look at his recently co-edited book, “A European Health Union: A Blueprint for Generations”, published in October 2023.

Read more

23/10/2023

All Policies for a Healthy Europe launches its European health and well-being deal

Take action by circulating widely this recently launched manifesto that includes some great potential recommendations on digital empowerment and health prevention. 

Read more

18/10/2023

Opt-in or opt-out on secondary use of data? Recent multi-stakeholder discussions

A multi-stakeholder meeting took place with European Union officials on 6 September 2023. It covered the implications of the potential adoption of an opt-out option to the secondary uses of health data in the European Health Data Space. EHTEL was among the attendees.

Read more